A panel of reference ligands representing diverse chemotypes including TT-OAD2, PF-06882961 (danuglipron), LY3502970 (orforglipron), CHU-128, GSBR-1290 (aleniglipron), and AZD5004 (Figure 2) was used to derive the ligand-centered models described below
Canada approves second generic semaglutide, the first G7 country to do so Health Canada Health Canada announcement, May 1, 2026
As yet, modest genetic studies have nominated a few risk genes that explain only a small percentage of the risk
Creative Light 1 and Creative Light 1 Plus are the first battery-powered and completely wireless creative LED systems by GLP for maximum flexibility in an almost unlimited range of applications
What does excluded from coverage mean on a denial letter